Ann: ARR grows to $64.7m and record cash receipts of $13m, page-50

First 50 Last

Share
Profile

Follow
xr

1,005 Posts.

135

28/01/21

16:53

Post #: 50512460
Share

Originally posted by alpha100: ↑

So of the two potential new huge clients, one is in Europe and at around the 51 minute mark Karl mentioned that the US one is a healthcare company.

A bit of a conspiracy theory here, but it occurred to me, and I am totally serious, that Karl and Peter might not want the share price to go higher. Anyone with half a brain can see that they are half dodgy at the very least - constantly not delivering on promises and more corporate governance issues than you can poke a stick at. They very nearly got a strike on the Remuneration report the last two years in a row and as the share price eventually appreciates it will result in higher institutional ownership which will likely get them at least one strike (resulting in them having to pay themselves less) and potentially two strikes in a row meaning the whole board gets rolled and they could lose their directorships.

In view of their shoddy track records over the last few years, if they’re not worried about this, then they faarking well should be!! I can’t wait to see the back of them myself.

Expand

Exactly. Snouts in the trough still, and costs rising again. What a joke. The fans are yet to convince me (and it appears others on here) that we shouldn't cut our colective losses and move on. Oh, did we mention the legal fees WE have just paid?. Christ. Unbelievable. And what, to his 'brother'? Kidding here are we?

LVT Price at posting: 21.0¢ Sentiment: Sell Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

CC9

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

FFM

Firefly positioned for copper growth in Canada ahead of resource update

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 40 more messages in this thread...

First 50 Last

Add LVT (ASX) to my watchlist

Ann: ARR grows to $64.7m and record cash receipts of $13m, page-50

Top Stories

Chariot Corp unveils plans for Black Mountain "pilot mine" in Wyoming, US; shares jump +20%

Firefly positioned for copper growth in Canada ahead of resource update

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News